OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
60396855

Nantong Acetic Acid Chemical Co Ltd

Specialty ChemicalsVerified

Nantong Acetic Acid Chemical Co Ltd has a debt-to-equity ratio of 0.44, indicating a relatively conservative capital structure. However, the company reported negative operating cash flow of -83.16 million CNY and negative operating income of -19.79 million CNY, signaling liquidity challenges. The current ratio of 1.79 suggests the company can cover its short-term liabilities with its short-term assets, but the negative net cash position after subtracting total debt raises concerns about its ability to meet long-term obligations. Profitability metrics are weak, with a return on equity of -0.88% and a return on assets of -0.48%. These figures fall significantly below the industry median for Specialty Chemicals, which typically sees positive returns in both categories. The company's gross profit margin of 8.66% (67.38 million CNY on 778.03 million CNY revenue) is also below the median for its industry, indicating cost pressures or pricing challenges. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or supply chain disruptions. The absence of segment or geographic breakdown in the financials suggests a high concentration risk. Looking ahead, the company is expected to face continued headwinds. Revenue is projected to decline in the current fiscal year, with no clear signs of recovery in the next fiscal year. The negative operating income and cash flow trends suggest a challenging growth trajectory, with no material capital expenditures or R&D investments to signal long-term value creation. The risk assessment highlights liquidity as a medium concern, with the company's negative net cash position after subtracting total debt being a key flag. Dilution risk is currently low, as there is no indication of share issuance or dilution pressure in the near term. However, the company's negative operating performance and weak cash flow could lead to future financing needs, potentially increasing dilution risk. Recent filings and transcripts do not provide additional insight into the company's strategic direction or operational performance. The lack of detailed disclosures in the latest financial statements and the absence of forward-looking guidance from management suggest limited transparency, which could affect investor confidence.

30-day price · 603968-0.95 (-7.5%)
Low$11.45High$14.22Close$11.75As of15 May, 00:00 UTC
Profile
CompanyNantong Acetic Acid Chemical Co Ltd
Ticker603968.SS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Nantong Acetic Acid Chemical Co Ltd produces and sells acetic acid and related chemical products, primarily serving the chemical manufacturing and industrial sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a confidence level of 0.92 based on verified market data.

Nantong Acetic Acid Chemical Co Ltd has a debt-to-equity ratio of 0.44, indicating a relatively conservative capital structure. However, the company reported negative operating cash flow of -83.16 million CNY and negative operating income of -19.79 million CNY, signaling liquidity challenges. The current ratio of 1.79 suggests the company can cover its short-term liabilities with its short-term assets, but the negative net cash position after subtracting total debt raises concerns about its ability to meet long-term obligations. Profitability metrics are weak, with a return on equity of -0.88% and a return on assets of -0.48%. These figures fall significantly below the industry median for Specialty Chemicals, which typically sees positive returns in both categories. The company's gross profit margin of 8.66% (67.38 million CNY on 778.03 million CNY revenue) is also below the median for its industry, indicating cost pressures or pricing challenges. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or supply chain disruptions. The absence of segment or geographic breakdown in the financials suggests a high concentration risk. Looking ahead, the company is expected to face continued headwinds. Revenue is projected to decline in the current fiscal year, with no clear signs of recovery in the next fiscal year. The negative operating income and cash flow trends suggest a challenging growth trajectory, with no material capital expenditures or R&D investments to signal long-term value creation. The risk assessment highlights liquidity as a medium concern, with the company's negative net cash position after subtracting total debt being a key flag. Dilution risk is currently low, as there is no indication of share issuance or dilution pressure in the near term. However, the company's negative operating performance and weak cash flow could lead to future financing needs, potentially increasing dilution risk. Recent filings and transcripts do not provide additional insight into the company's strategic direction or operational performance. The lack of detailed disclosures in the latest financial statements and the absence of forward-looking guidance from management suggest limited transparency, which could affect investor confidence.
Key takeaways
  • The company is operating at a loss with negative operating income and cash flow, indicating significant financial stress.
  • Return on equity and return on assets are negative, well below industry medians, signaling poor profitability.
  • The company's revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
  • Liquidity is a medium concern due to negative net cash after subtracting total debt.
  • No dilution pressure is currently evident, but the company's financial performance could change this outlook.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$778.0M
Gross profit$67.4M
Operating income-$19.8M
Net income-$17.2M
R&D
SG&A
D&A
SBC
Operating cash flow-$83.2M
CapEx-$24.1M
Free cash flow
Total assets$3.60B
Total liabilities$1.64B
Total equity$1.96B
Cash & equivalents
Long-term debt$872.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$3.00B$203.5M$174.1M-$55.4M
FY-3$3.59B$470.2M$401.5M$244.0M
FY-2$3.01B$34.6M$32.7M-$98.7M
FY-1$2.95B-$104.4M-$103.8M-$143.2M
FY0$2.63B-$52.0M-$58.7M$5.6M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$2.78B$1.79B
FY-3$3.17B$2.09B
FY-2$3.55B$1.99B$2.2M
FY-1$3.36B$1.83B$18.1k
FY0$3.29B$1.77B
PeriodOCFCapExFCFSBC
FY-4$164.8M-$191.3M-$55.4M
FY-3$326.2M-$101.0M$244.0M
FY-2$198.1M-$45.2M-$98.7M
FY-1$177.8M-$76.7M-$143.2M
FY0-$2.6M-$44.2M$5.6M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$778.0M-$19.8M-$17.2M
FQ-6$702.8M-$51.0M-$49.6M
FQ-5$754.5M-$5.9M-$10.0M
FQ-4$688.2M-$6.9M-$6.7M
FQ-3$710.8M$14.6M$9.3M
FQ-2$592.2M-$30.8M-$26.8M
FQ-1$639.4M-$31.5M-$34.4M
FQ0$644.4M-$18.2M-$18.1M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$3.60B$1.96B
FQ-6$3.47B$1.86B$471.2M
FQ-5$3.36B$1.83B$18.1k
FQ-4$3.57B$1.82B$731.1M
FQ-3$3.46B$1.84B
FQ-2$3.41B$1.81B$339.9M
FQ-1$3.29B$1.77B
FQ0$3.33B$1.75B$636.1M
PeriodOCFCapExFCFSBC
FQ-7-$83.2M-$24.1M
FQ-6-$24.5M-$38.4M
FQ-5$177.8M-$76.7M
FQ-4-$139.8M-$19.7M
FQ-3-$56.4M-$24.2M
FQ-2-$123.6M-$29.8M
FQ-1-$2.6M-$44.2M
FQ0-$199.5M-$9.6M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.96B
Net cash-$872.2M
Current ratio1.8
Debt/Equity0.4
ROA-0.5%
ROE-0.9%
Cash conversion4.8%
CapEx/Revenue-3.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
Metric603968Activity
Op margin-2.5%5.5% medp25 -0.0% · p75 10.8%bottom quartile
Net margin-2.2%4.1% medp25 0.1% · p75 8.8%bottom quartile
Gross margin8.7%20.5% medp25 12.4% · p75 29.7%bottom quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-3.1%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity44.0%37.1% medp25 10.3% · p75 82.0%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 04:34 UTC#1ad42ce0
Market quoteclose CNY 12.29 · shares 0.20B diluted
no public URL
2026-05-07 04:34 UTC#c0ea84d0
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 01:05 UTCJob: 32b8d3e6